Markets:

Overview

News

Currencies

International

Treasuries

Scholar Rock Holding Corporation - Common Stock (NQ:SRRK)

41.66 -2.00 (-4.59%)

Streaming Delayed Price Updated: 11:56 AM EDT, Mar 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Scholar Rock Holding Corporation - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

67 Biggest Movers From Yesterday ↗

June 22, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.

Via Benzinga

45 Stocks Moving In Tuesday's Mid-Day Session ↗

June 21, 2022

Gainers Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Why Scholar Rock Shares Are Trading Higher Today ↗

June 17, 2022

Via Benzinga

Scholar Rock Shares Jumps On Updating Strategic Priorities ↗

May 17, 2022

Via Benzinga

Recap: Scholar Rock Holding Q1 Earnings ↗

May 16, 2022

Scholar Rock Holding (NASDAQ:SRRK) reported its Q1 earnings results on Monday, May 16, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Via Benzinga

Dow Jones Turns Lower; Revlon Shares Jump ↗

June 17, 2022

U.S. stocks pared gains midway through trading, with the Dow Jones dropping around 100 points on Friday.

Via Benzinga

33 Stocks Moving In Friday's Mid-Day Session ↗

June 17, 2022

Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.

Via Benzinga

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease ↗

June 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

U.S. Markets Open Higher; Dow Rises Around 200 Points ↗

June 17, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Friday.

Via Benzinga

Scholar Rock Announces $205 Million Registered Direct Offering

June 17, 2022

From Scholar Rock

Via Business Wire

Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 and 3 Spinal Muscular Atrophy (SMA)

June 17, 2022

From Scholar Rock

Via Business Wire

Scholar Rock to Present New Apitegromab Data Including 24-Month Efficacy and Safety Data from TOPAZ Phase 2 Trial at the 2022 Annual Cure SMA Conference

June 09, 2022

From Scholar Rock

Via Business Wire

79 Biggest Movers From Yesterday ↗

June 08, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 07, 2022

Gainers

Via Benzinga

Scholar Rock to Present at Jefferies Global Healthcare Conference 2022

June 02, 2022

From Scholar Rock

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

What 4 Analyst Ratings Have To Say About Scholar Rock Holding ↗

May 24, 2022

Over the past 3 months, 4 analysts have published their opinion on Scholar Rock Holding (NASDAQ:SRRK) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

81 Biggest Movers From Yesterday ↗

May 18, 2022

Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.

Via Benzinga

Mid-Day Market Update: Nasdaq Jumps 200 Points; AutoWeb Shares Slide ↗

May 17, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite adding 200 points on Tuesday.

Via Benzinga

48 Stocks Moving In Tuesday's Mid-Day Session ↗

May 17, 2022

Gainers Okyo Pharma Ltd. ADR (NASDAQ: OKYO) gained 30% to $5.20 as the company priced its IPO at $4 per ADS.

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Walmart Earnings Miss Estimates ↗

May 17, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Tuesday.

Via Benzinga

Scholar Rock Reports First Quarter 2022 Financial Results and Updates Strategic Priorities

May 16, 2022

From Scholar Rock

Via Business Wire

Scholar Rock Presents Data Analysis of Multiple Efficacy Endpoints from the Apitegromab TOPAZ Phase 2 Trial at the 2022 European Paediatric Neurology Society Congress

April 21, 2022

From Scholar Rock

Via Business Wire

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy ↗

April 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight ↗

April 03, 2022

Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022 ↗

March 23, 2022

Upgrades For E2open Parent Holdings Inc (NYSE:ETWO), Colliers Securities upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $14.58 and...

Via Benzinga

Scholar Rock Presents Data Analysis of Multiple Efficacy Endpoints from the Apitegromab TOPAZ Phase 2 Trial at the American Academy of Neurology 2022 Annual Meeting

March 22, 2022

From Scholar Rock

Via Business Wire

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.